YU107884A - Process for preparation of new 7-piperidino-1,2,3,5-tetra-hydro-imidazo - Google Patents

Process for preparation of new 7-piperidino-1,2,3,5-tetra-hydro-imidazo

Info

Publication number
YU107884A
YU107884A YU01078/84A YU107884A YU107884A YU 107884 A YU107884 A YU 107884A YU 01078/84 A YU01078/84 A YU 01078/84A YU 107884 A YU107884 A YU 107884A YU 107884 A YU107884 A YU 107884A
Authority
YU
Yugoslavia
Prior art keywords
piperidino
imidazo
hydro
tetra
preparation
Prior art date
Application number
YU01078/84A
Other versions
YU43576B (en
Inventor
F Ishikawa
S Ashida
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of YU107884A publication Critical patent/YU107884A/en
Publication of YU43576B publication Critical patent/YU43576B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • C07D239/96—Two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Lubricants (AREA)
  • Furan Compounds (AREA)

Abstract

7-Piperidino-1,2,3,5-tetrahydroimidazo[2,1-b]-quinazolin-2-one having platelet aggregation inhibitory activity is disclosed. The compound has high water-solubility and reduced influences on the circulatory system.
YU1078/84A 1983-06-21 1984-06-20 PROCESS FOR PREPARATION OF 7-PIPERIDINO-1,2,3,5-TETRA-HYDRO-IMIDAZO(2,1-b) QUINAZOLINE-2-ONES YU43576B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58111498A JPS604186A (en) 1983-06-21 1983-06-21 Imidazoquinazoline compound

Publications (2)

Publication Number Publication Date
YU107884A true YU107884A (en) 1986-10-31
YU43576B YU43576B (en) 1989-08-31

Family

ID=14562811

Family Applications (1)

Application Number Title Priority Date Filing Date
YU1078/84A YU43576B (en) 1983-06-21 1984-06-20 PROCESS FOR PREPARATION OF 7-PIPERIDINO-1,2,3,5-TETRA-HYDRO-IMIDAZO(2,1-b) QUINAZOLINE-2-ONES

Country Status (19)

Country Link
US (1) US4596806A (en)
EP (1) EP0129258B1 (en)
JP (1) JPS604186A (en)
KR (1) KR910003153B1 (en)
AT (1) ATE29884T1 (en)
AU (1) AU558124B2 (en)
CA (1) CA1231946A (en)
DE (1) DE3466392D1 (en)
DK (1) DK162999C (en)
ES (1) ES8603483A1 (en)
FI (1) FI77864C (en)
GR (1) GR81629B (en)
IE (1) IE57736B1 (en)
IL (1) IL72188A (en)
NO (1) NO161220C (en)
PH (1) PH19413A (en)
PT (1) PT78775A (en)
YU (1) YU43576B (en)
ZA (1) ZA844437B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663320A (en) * 1983-02-16 1987-05-05 Syntex (U.S.A.) Inc. (2-oxo-1,2,3,5-tetrahydroimidazo[2,1-b]quinoazolinyl)oxyalkylamides, compositions and the use thereof
JPS6028979A (en) * 1983-07-14 1985-02-14 Dai Ichi Seiyaku Co Ltd Imidazoquinazoline compound
IL74349A (en) * 1984-02-15 1988-07-31 Syntex Inc (2-oxo-1,2,3,5-tetrahydroimidazo(2,1-b)quinazolinyl)-oxyalkylamides,their preparation and pharmaceutical compositions containing them
US4783467A (en) * 1985-06-05 1988-11-08 Pfizer Inc. Tetrahydroimidazoquinazolinone inotropic agents
US4837239A (en) * 1985-08-23 1989-06-06 Syntex (U.S.A.) Inc. Cardiotonic phosphodiesterase inhibitors complexed with water soluble vitamins
US4670434A (en) * 1985-11-14 1987-06-02 Syntex (U.S.A.) Inc. (2-oxo-3-methylene-1,2,3,5-tetrahydroimidazo[2,1-b]quinazolinyl)oxyalkylamides useful as cyclic AMP phosphodiesterase inhibitors
US4766126A (en) * 1986-01-10 1988-08-23 Daiichi Seiyaku Co., Ltd. Process for treatment of nephritis with imidazoquinazolines
US4775674A (en) * 1986-05-23 1988-10-04 Bristol-Myers Company Imidazoquinolinylether derivatives useful as phosphodiesterase and blood aggregation inhibitors
US4701459A (en) * 1986-07-08 1987-10-20 Bristol-Myers Company 7-amino-1,3-dihydro-2H-imidazo[4,5-b]quinolin 2-ones and method for inhibiting phosphodiesterase and blood platelet aggregation
US4761416A (en) * 1986-07-25 1988-08-02 Syntex (U.S.A.) Inc. N-N-disubstituted-ω-[2-amino-3-(carbonylmethyl)-3, 4-dihydroquinazolinyl]oxyalkylamides and related compounds
US6818613B2 (en) * 2001-11-07 2004-11-16 Ortho-Mcneil Pharmaceutical, Inc. Aqueous sustained-release formulations of proteins

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932407A (en) * 1973-11-19 1976-01-13 Bristol-Myers Company Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones
US3983119A (en) * 1974-11-06 1976-09-28 Bristol-Myers Company Process for the preparation of optionally substituted 1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-ones
US3983120A (en) * 1974-11-06 1976-09-28 Bristol-Myers Company Process for the preparation of optionally substituted 1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-ones
NL7807507A (en) * 1977-07-25 1979-01-29 Hoffmann La Roche TRICYCLICAL CONNECTIONS.
US4208521A (en) * 1978-07-31 1980-06-17 Bristol-Myers Company Process for the preparation of imidazo[2,1-b]quinazolinones
US4455311A (en) * 1981-08-28 1984-06-19 Hoffmann-La Roche Inc. Imidazoquinazoline derivatives which inhibit the aggregation of blood platelets, inhibit gastric secretion or have activity on the circulatory system

Also Published As

Publication number Publication date
DK290084D0 (en) 1984-06-13
DE3466392D1 (en) 1987-10-29
FI842532A (en) 1984-12-22
KR910003153B1 (en) 1991-05-20
DK162999B (en) 1992-01-06
GR81629B (en) 1984-12-11
NO842502L (en) 1984-12-27
ZA844437B (en) 1985-01-30
AU558124B2 (en) 1987-01-22
IL72188A (en) 1987-03-31
KR850000442A (en) 1985-02-27
JPS635030B2 (en) 1988-02-01
CA1231946A (en) 1988-01-26
DK290084A (en) 1984-12-22
DK162999C (en) 1992-06-01
ATE29884T1 (en) 1987-10-15
AU2943284A (en) 1985-01-03
ES533609A0 (en) 1985-12-16
PH19413A (en) 1986-04-10
JPS604186A (en) 1985-01-10
FI77864B (en) 1989-01-31
IE841549L (en) 1984-12-21
PT78775A (en) 1984-07-01
NO161220C (en) 1989-07-19
ES8603483A1 (en) 1985-12-16
YU43576B (en) 1989-08-31
EP0129258A1 (en) 1984-12-27
US4596806A (en) 1986-06-24
EP0129258B1 (en) 1987-09-23
NO161220B (en) 1989-04-10
IE57736B1 (en) 1993-03-24
FI842532A0 (en) 1984-06-21
IL72188A0 (en) 1984-10-31
FI77864C (en) 1989-05-10

Similar Documents

Publication Publication Date Title
EP0133913A3 (en) Process for the preparation of 3,3-dichloro-2-methyl propene
YU81685A (en) Process for preparation of derivatives of glycerophospholines and glycerophosphoethanolamines
YU107884A (en) Process for preparation of new 7-piperidino-1,2,3,5-tetra-hydro-imidazo
NO157099C (en) PROCESS FOR THE MANUFACTURE OF 1,8-DIHYDROXY-10-ACYL-9-ANTHRON DERIVATIVES.
AU570070B2 (en) Dibromobenzylcyclohexylamine compounds for the treatment of infections
FR2549039B1 (en) PROCESS FOR THE PREPARATION OF 3,3,3-TRIFLUORO-2-TRIFLUORO-MEHYLPROPENE
FI860247A0 (en) PROCEDURE FOR FRAMSTATION OF 4,4-DIALKYL-2-AZETIDINONER.
DE3468207D1 (en) Process for the preparation of 1,4-butanediol
DE3378823D1 (en) Process for the preparation of 2,4,5,6-tetrachloropyrimidine
OA08376A (en) 3,7-disubstituted-3-cephem compounds and processes for production of the same.
DE3267707D1 (en) Process for the preparation of 1-formyl-2,6,6-trimethyl-cyclohex-1-ene derivatives
ZA865351B (en) 3,7-disubstituted-3-cephem compounds and processes for production of the same
ES518725A0 (en) PROCEDURE FOR THE PREPARATION OF NEW DERIVATIVES OF AZABICICLO (3.2.0) HEPTANE.
DE3360408D1 (en) Process for the production of an araliphatic aldehyde, and agents for its production
GB2165242B (en) Process for the preparation of 1, 2-benzoxathiine derivatives
PT81633B (en) Process for the preparation of 1,4-dihydropiridine derivatives
DE3363751D1 (en) Process for the preparation of 4,4-dimethyl-tetrahydrofuran-2,3 dione
AU8825782A (en) Process for the preparation of urea
GB2151626B (en) Process for the preparation of 3,4,5-trimethoxy-benzonitrile
AU8825882A (en) Process for the preparation of urea
DE3572475D1 (en) Process for the preparation of 3,7-bisacetaminoheptan-2-one
EP0115324A3 (en) Process for the preparation of 2,4,5,6-tetraaminopyrimidine-sulphate
IL72482A (en) Process for the preparation of 3-exomethylene-5,5-dioxocephalosporin and novel compounds of this type
ZA811440B (en) Process for the preparation of n,n-dimethyl-10-(1-aza-(2,2,2)-bicyclo-3-octyl)-10h-2-phenothiayine sulphonamide
OA08022A (en) Process for the preparation of urea.